Thrivent Financial for Lutherans Grows Position in Cognex Corporation $CGNX

Thrivent Financial for Lutherans raised its position in Cognex Corporation (NASDAQ:CGNX) by 45.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 88,043 shares of the scientific and technical instruments company’s stock after buying an additional 27,673 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Cognex were worth $2,792,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Geneos Wealth Management Inc. boosted its stake in Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the period. Penserra Capital Management LLC purchased a new stake in shares of Cognex in the second quarter valued at about $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Cognex during the second quarter worth about $29,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock worth $34,000 after buying an additional 756 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its position in Cognex by 31.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock valued at $40,000 after acquiring an additional 306 shares during the period. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Cognex Stock Performance

Cognex stock opened at $36.58 on Tuesday. The company has a market cap of $6.13 billion, a P/E ratio of 57.16 and a beta of 1.53. Cognex Corporation has a one year low of $22.67 and a one year high of $49.76. The business has a fifty day moving average of $40.03 and a two-hundred day moving average of $39.41.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The business had revenue of $264.00 million during the quarter, compared to the consensus estimate of $261.86 million. During the same quarter last year, the firm posted $0.20 EPS. The business’s revenue was up 18.0% compared to the same quarter last year. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Sell-side analysts predict that Cognex Corporation will post 0.61 EPS for the current year.

Cognex Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Thursday, November 13th were given a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Thursday, November 13th. This is a positive change from Cognex’s previous quarterly dividend of $0.08. Cognex’s payout ratio is 53.13%.

Analyst Upgrades and Downgrades

CGNX has been the topic of several analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a research note on Monday, December 15th. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $35.00 price objective (down from $45.00) on shares of Cognex in a research report on Wednesday, December 3rd. The Goldman Sachs Group raised shares of Cognex from a “sell” rating to a “buy” rating and boosted their price objective for the company from $42.00 to $50.00 in a research note on Tuesday, December 16th. UBS Group restated a “buy” rating and issued a $58.00 target price on shares of Cognex in a research note on Friday, October 31st. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $50.00 target price on shares of Cognex in a report on Friday, October 31st. Nine research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Cognex presently has a consensus rating of “Hold” and an average target price of $45.79.

Insider Activity at Cognex

In related news, Director Robert Willett sold 6,704 shares of the company’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.60% of the stock is owned by company insiders.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.